These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23441712)

  • 1. The year in immune intervention for type 1 diabetes.
    Skyler JS
    Diabetes Technol Ther; 2013 Feb; 15 Suppl 1():S88-95. PubMed ID: 23441712
    [No Abstract]   [Full Text] [Related]  

  • 2. New therapies for diabetes management.
    Garg SK
    Diabetes Technol Ther; 2013 Feb; 15 Suppl 1():S126-35. PubMed ID: 23441701
    [No Abstract]   [Full Text] [Related]  

  • 3. For parents. Type 1 diabetes research. Balancing hope with realism.
    Dinsmoor RS
    Diabetes Self Manag; 2003; 20(2):87-8, 91-2, 95, 99-102. PubMed ID: 12715738
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on global intervention studies in type 1 diabetes.
    Chiang JL; Haller MJ; Schatz DA
    Endocrinol Metab Clin North Am; 2012 Dec; 41(4):695-712. PubMed ID: 23099265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunoprevention of Type I diabetes mellitus].
    Spinas GA
    Ther Umsch; 1996 Dec; 53(12):882-8. PubMed ID: 9036566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppression trials in type I diabetes].
    Feutren G; Boitard C; Assan R; Bach JF
    Journ Annu Diabetol Hotel Dieu; 1987; ():147-69. PubMed ID: 3302472
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunosuppression in Type I diabetes mellitus].
    Schönle EJ; Sizonenko PC; Spinas GA
    Schweiz Rundsch Med Prax; 1990 Oct; 79(41):1225-7. PubMed ID: 2237051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 diabetes immunotherapy: is the glass half empty or half full?
    Herold KC; Bluestone JA
    Sci Transl Med; 2011 Aug; 3(95):95fs1. PubMed ID: 21832236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in the immunointervention of type-1 diabetes mellitus.
    Schernthaner G
    Horm Metab Res; 1995 Dec; 27(12):547-54. PubMed ID: 8750784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes technology and treatment in the pediatric age group.
    Shalitin S; Chase HP
    Diabetes Technol Ther; 2013 Feb; 15 Suppl 1():S107-16. PubMed ID: 23441699
    [No Abstract]   [Full Text] [Related]  

  • 11. Is insulin-dependent diabetes mellitus a preventable disease?
    Maclaren NK; Riley WJ; Winter WE; Silverstein JH
    Clin Invest Med; 1987 Sep; 10(5):444-9. PubMed ID: 3315366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunointervention in newly diagnosed type 1 diabetes].
    Kaupper T; Walter M; Ziegler AG
    Dtsch Med Wochenschr; 2006 Dec; 131(49):2783-8. PubMed ID: 17136660
    [No Abstract]   [Full Text] [Related]  

  • 13. [Progress in the therapy of diabetes].
    Raptis S; Rothenbuchner G; Pfeiffer EF
    Wien Med Wochenschr; 1971 Apr; 121(14):261-9. PubMed ID: 5559791
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunosuppression in juvenile diabetes mellitus? Critical viewpoint on the treatment with cyclosporin A with consideration of the differential etiology].
    Teuber J; Usadel KH
    Fortschr Med; 1985 Jul; 103(27-28):707-13. PubMed ID: 4029865
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial Comment on type 1 diabetes and antigen-specific immunotherapy.
    Lernmark Å; Larsson HE
    J Intern Med; 2011 Aug; 270(2):132-5. PubMed ID: 21668820
    [No Abstract]   [Full Text] [Related]  

  • 16. Interference with islet-specific homing of autoreactive T cells: an emerging therapeutic strategy for type 1 diabetes.
    Savinov AY; Burn P
    Drug Discov Today; 2010 Jul; 15(13-14):531-9. PubMed ID: 20685342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus.
    Eldor R; Cohen IR; Raz I
    Int Rev Immunol; 2005; 24(5-6):327-39. PubMed ID: 16318985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging treatments for the prevention of type 1 diabetes.
    Raskin P; Mohan A
    Expert Opin Emerg Drugs; 2010 Jun; 15(2):225-36. PubMed ID: 20384544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outlook for immune intervention in type I diabetes.
    Grob PJ
    Curr Probl Clin Biochem; 1983; 12():119-40. PubMed ID: 6360542
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of CD3-specific antibodies in autoimmune diabetes: a step toward the induction of immune tolerance in the clinic.
    Chatenoud L
    Handb Exp Pharmacol; 2008; (181):221-36. PubMed ID: 18071948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.